Antimicrobial Resistance

1. Introduction

Antimicrobial Resistance (AMR) is the ability of microorganisms such as bacteria, viruses, fungi, and parasites to resist the effects of antimicrobial medicines, making standard treatments ineffective and allowing infections to persist and spread. Antimicrobial medicines include antibiotics, antivirals, antifungals, antimalarials, and antiparasitic drugs. Antimicrobial Resistance develops naturally through genetic changes in microorganisms; however, its emergence and spread have been significantly accelerated by the irrational and excessive use of antimicrobial drugs in humans, animals, and agriculture. Microorganisms that become resistant to multiple drugs are commonly referred to as “superbugs.” These Antimicrobial Resistance Causes make AMR an important topic in Antimicrobial Resistance Notes for UPSC and BPSC preparation.

The World Health Organization (WHO) has identified Antimicrobial Resistance as one of the top ten global public health threats. According to a landmark study published in The Lancet (2022), about 1.27 million deaths were directly attributable to bacterial AMR in 2019, while 4.95 million deaths were associated with drug-resistant bacterial infections worldwide, highlighting the growing global health crisis.

India bears one of the highest burdens of antimicrobial resistance due to its large population, high prevalence of infectious diseases, widespread misuse of antibiotics, and inadequate infection control practices. Consequently, Antimicrobial Resistance has emerged as a major challenge to achieving Universal Health Coverage (UHC) and the Sustainable Development Goals (SDGs).

2. Reasons for Antimicrobial Resistance (AMR)

Overuse and Misuse of Antimicrobial Drugs

• Excessive and irrational use of antibiotics, antivirals, antifungals, and antiparasitic medicines is the primary driver of Antimicrobial Resistance. Antibiotics are often prescribed for viral infections such as the common cold and influenza, against which they are ineffective, accelerating the development of resistant microorganisms.
• Self-medication, over-the-counter availability, and pressure on doctors to prescribe antibiotics further worsen the problem. According to the WHO, nearly 50% of antibiotics used globally are prescribed or consumed inappropriately, increasing selective pressure on microbes to evolve resistance. These are among the major Antimicrobial Resistance Causes.

Incomplete Treatment and Poor Patient Compliance

• Many patients discontinue antibiotics once symptoms improve instead of completing the prescribed course. This allows partially resistant microorganisms to survive, multiply, and spread resistance genes to other microbes.
• Poor adherence to treatment is particularly problematic in diseases such as tuberculosis (TB). India accounts for about 27% of the world’s TB burden, making strict compliance with treatment protocols essential to prevent the emergence of Multi-Drug-Resistant Tuberculosis (MDR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-TB). This is an important concern under Antimicrobial Resistance and Antibiotic Resistance in India.

Excessive Use of Antibiotics in Livestock and Agriculture

• Antibiotics are widely used in livestock, poultry, aquaculture, and veterinary medicine to promote growth and prevent diseases. Continuous exposure to these drugs leads to the emergence of resistant bacteria, which can reach humans through contaminated food, water, or direct animal contact.
• Recognising this interconnection, the WHO, FAO, and WOAH (World Organisation for Animal Health) advocate the One Health Approach, integrating human, animal, and environmental health to combat AMR.

Poor Infection Prevention and Healthcare Infrastructure

• Inadequate sanitation, unsafe drinking water, poor hygiene, overcrowding, and weak infection control practices increase the spread of infectious diseases, leading to greater dependence on antimicrobial drugs.
• Hospital-acquired infections (HAIs) caused by resistant bacteria are a growing concern, particularly in Intensive Care Units (ICUs). Improving hand hygiene, vaccination coverage, sterilisation practices, and hospital infection control can significantly reduce antibiotic consumption and the spread of resistant pathogens.

Weak Surveillance, Limited Awareness and Slow Drug Development

• Many countries, including India, face challenges such as limited laboratory capacity, inadequate AMR surveillance, and low public awareness, making it difficult to detect and contain resistant infections. In addition, the development of new antibiotics has slowed considerably because of high research costs and low commercial returns, reducing the availability of effective treatment options against emerging “superbugs.”

These factors together explain several important Antimicrobial Resistance Causes and are particularly relevant for AMR in India.

3. Implications of Antimicrobial Resistance (AMR)

Public Health Crisis

• Antimicrobial Resistance makes common bacterial, viral, fungal, and parasitic infections difficult or impossible to treat, leading to prolonged illness, disability, and increased mortality. Diseases such as pneumonia, tuberculosis (TB), urinary tract infections (UTIs), malaria, and bloodstream infections are becoming increasingly difficult to manage due to drug resistance.
• According to The Lancet (2022), 1.27 million deaths were directly attributable to bacterial AMR in 2019, while 4.95 million deaths were associated with drug-resistant infections, making Antimicrobial Resistance one of the leading global causes of death.

Increased Healthcare Costs

• Drug-resistant infections require costlier second- or third-line medicines, prolonged hospitalization, repeated laboratory investigations, and intensive care, significantly increasing healthcare expenditure for individuals and governments.
• The World Bank estimates that by 2030, AMR could push up to 24 million people into extreme poverty, particularly in low- and middle-income countries, due to rising healthcare costs and productivity losses.

Threat to Modern Medical Procedures

• The success of major surgeries, organ transplantation, cancer chemotherapy, dialysis, neonatal care, and intensive care treatment depends on the availability of effective antibiotics to prevent and treat infections.
• As Antimicrobial Resistance increases, these life-saving medical procedures become riskier, raising postoperative complications and mortality. Experts warn that unchecked AMR could push healthcare towards a “pre-antibiotic era,” where even minor infections may become life-threatening.

Economic and Food Security Impact

• AMR reduces labour productivity by increasing illness, absenteeism, and premature deaths, thereby affecting economic growth. It also impacts the livestock, poultry, fisheries, and agriculture sectors, where resistant infections reduce animal productivity and increase production costs.
• The World Bank projects that, under a high-AMR scenario, global GDP could decline by up to 3.8% annually by 2050, highlighting the enormous economic consequences of unchecked Antimicrobial Resistance.

Emergence and Spread of “Superbugs”

• Continuous misuse of antimicrobial drugs has led to the emergence of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) microorganisms, commonly known as “superbugs.” These pathogens are resistant to multiple classes of antimicrobial medicines, leaving very limited treatment options.
• Examples include Methicillin-resistant Staphylococcus aureus (MRSA), Carbapenem-resistant Enterobacteriaceae (CRE), and Multidrug-Resistant Tuberculosis (MDR-TB), all of which pose serious challenges to public health systems worldwide. These impacts are important for understanding Antimicrobial Resistance and preparing comprehensive Antimicrobial Resistance Notes.

4. Measures to Control Antimicrobial Resistance (AMR)

(i) Global Initiatives

• The World Health Organization (WHO) adopted the Global Action Plan on AMR (2015) based on the One Health Approach, integrating human, animal, and environmental health. It focuses on improving awareness, strengthening surveillance, preventing infections, optimizing antimicrobial use, and promoting research.
• The Global Antimicrobial Resistance and Use Surveillance System (GLASS), launched by WHO in 2015, supports countries in monitoring antimicrobial resistance and antimicrobial consumption through standardized surveillance systems.
• World Antimicrobial Awareness Week (WAAW) is observed annually from 18–24 November to promote responsible use of antimicrobials among healthcare professionals, policymakers, farmers, and the general public. These global measures are central to Antimicrobial Resistance Solutions.

(ii) Indian Initiatives

National Action Plan on Antimicrobial Resistance (NAP-AMR), 2017

• The National Action Plan on AMR (2017–2021) was launched by the Ministry of Health and Family Welfare in April 2017 in line with the WHO Global Action Plan. It adopts the One Health Approach, recognising that human health, animal health, agriculture, and the environment are interconnected.
• The plan focuses on six strategic priorities: improving public awareness, strengthening surveillance, reducing infection through better sanitation and infection control, promoting rational use of antimicrobials, encouraging research and innovation, and enhancing national and international collaboration.
• Several states, including Kerala, Madhya Pradesh, Delhi, Maharashtra, and Assam, have also prepared State Action Plans on AMR (SAP-AMR) to address local challenges. These measures are particularly important for addressing AMR in India and strengthening Antibiotic Resistance in India control efforts.

National Programme on AMR Containment

• The National Programme on AMR Containment was launched in 2012 to establish laboratory-based surveillance for antimicrobial resistance across India. Under the programme, AMR surveillance laboratories have been established in State Medical Colleges and tertiary healthcare institutions to monitor resistance trends and guide treatment policies.

Antimicrobial Resistance Surveillance and Research Network (AMRSN)

• The Indian Council of Medical Research (ICMR) established the AMR Surveillance and Research Network (AMRSN) in 2013 to generate reliable evidence on antimicrobial resistance patterns across the country.
• The network connects leading tertiary care hospitals and laboratories to monitor resistance among priority pathogens, develop treatment guidelines, and provide scientific evidence for national policy decisions.

Antibiotic Stewardship Programme (AMSP)

• The ICMR Antibiotic Stewardship Programme (AMSP) promotes the judicious use of antibiotics in hospitals by ensuring that the right antibiotic is prescribed in the right dose, for the right duration, and only when medically necessary.
• The programme aims to reduce unnecessary antibiotic use, particularly in Intensive Care Units (ICUs), thereby slowing the emergence of resistant microorganisms and improving patient outcomes. These initiatives form an important part of Antimicrobial Resistance Solutions in India.

Regulation of Antibiotic Sales

• India has strengthened the regulation of antibiotic use through Schedule H and Schedule H1 of the Drugs and Cosmetics Rules, under which several critical antibiotics can only be sold on a valid prescription.
• To curb irrational drug use, the Drug Controller General of India (DCGI) has also banned several irrational Fixed Dose Combinations (FDCs) of antibiotics that lacked scientific justification.

Research and International Collaboration

• The ICMR is actively supporting research for the development of new antibiotics, rapid diagnostic tools, vaccines, and alternative therapies through collaborations with national and international institutions.
• India has partnered with organizations such as the Research Council of Norway (RCN) and Germany’s Federal Ministry of Education and Research (BMBF) to strengthen collaborative research on antimicrobial resistance and accelerate innovation.

5. Way Forward

• Promote rational use of antimicrobials: Antibiotics should be prescribed only when medically necessary, and patients must complete the full course of treatment. Strict enforcement of prescription-only sale of antibiotics and expansion of Antibiotic Stewardship Programmes (AMSP) in hospitals are essential to reduce misuse.
• Strengthen surveillance through the One Health Approach: India should expand AMR surveillance across human health, livestock, agriculture, and the environment. Better laboratory infrastructure, integrated data sharing, and regular monitoring under the One Health framework will help detect and contain resistant pathogens at an early stage.
• Enhance infection prevention and public awareness: Improving vaccination coverage, sanitation, hand hygiene, hospital infection control, and antimicrobial awareness can significantly reduce the need for antibiotics. Public campaigns should discourage self-medication and educate people about the dangers of antimicrobial resistance.
• Promote research and innovation: Greater investment is needed in the development of new antibiotics, rapid diagnostic tests, vaccines, phage therapy, and alternative antimicrobial agents. Strengthening collaboration among government, academia, industry, and international organisations will accelerate innovation and improve preparedness against future resistant infections.

6. Conclusion

Antimicrobial Resistance (AMR) is a silent global health crisis that threatens the effectiveness of modern medicine by making common infections increasingly difficult to treat. Addressing Antimicrobial Resistance requires responsible use of antimicrobials, robust surveillance, strong infection prevention, research and innovation, and coordinated implementation of the One Health Approach. Timely and collective action is essential to safeguard public health, ensure food security, and achieve the SDGs.

BPSC Mains Practice Questions

1. “Antimicrobial Resistance (AMR) is not merely a health issue but a multidimensional challenge affecting India’s economy, food security and healthcare system.” Discuss the major causes and implications of AMR.
2. “The One Health Approach is essential for addressing Antimicrobial Resistance in India.” Examine the measures taken by India to control AMR and suggest a comprehensive way forward.

Learn More About Antimicrobial Resistance in India

For official information on Antimicrobial Resistance (AMR), national AMR initiatives, surveillance, antibiotic stewardship, and India’s efforts to address AMR, visit the Indian Council of Medical Research (ICMR), Government of India: Indian Council of Medical Research – Antimicrobial Resistance.